Generoso Nery
Family Medicine · Upland, CANPI 1851408116
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,957 and has fallen 66.8% since, to $651 in 2025. Among family medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 79 payments — averaging $48.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$515
- AstraZeneca$396
- Corcept Therapeutics$365
- Pfizer$227
- Novartis$225
- Novo Nordisk$196
- plus $2K from 17 others
What the payments were for
- Food & beverage$3,72197%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $515 |
| AstraZeneca | 12 | $396 |
| Corcept Therapeutics | 3 | $365 |
| Pfizer | 10 | $227 |
| Novartis | 8 | $225 |
| Novo Nordisk | 2 | $196 |
| Sanofi Pasteur Inc. | 2 | $194 |
| Astellas Pharma US Inc | 7 | $155 |
| Medicure Pharma Inc. | 1 | $148 |
| Neurocrine Biosciences, Inc. | 1 | $140 |
| Amgen | 1 | $129 |
| Intra-sana Laboratories | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Biohaven Pharmaceuticals, Inc. | 1 | $124 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Smith+Nephew | 1 | $122 |
| Sanofi-aventis U.S. LLC | 4 | $111 |
| Sunovion Pharmaceuticals Inc. | 1 | $101 |
| Dexcom, Inc. | 1 | $78 |
| Boehringer Ingelheim | 4 | $70 |
| Teva Pharmaceuticals USA, Inc. | 1 | $63 |
| AbbVie | 4 | $58 |
| Merck | 2 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Korlym$365
- INVOKANA$225
- ZYPITAMAG (pitavastatin)$148
- INGREZZA$140
- Repatha$129
- VOQUEZNA$125
- Reltone 200 Mg$125
- GLYCATE$125
- Reltone 400 Mg$125
- NURTEC ODT$124
- REXULTI$122
- Santyl$122
- ENTRESTO$117
- Ozempic$117
- FARXIGA$115
- APTIOM$101
How this compares
$3,821 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Other family medicine in Upland
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
- Amira AyadBakersfield$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.